Clinical Trial Update: Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating paclitaxel in patients with metastatic or recurrent salivary gland cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED